(Q53286814)
Statements
Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up. (English)
Alfredo Pece
Vincenzo Isola
Stefano Piermarocchi
Giliola Calori
3 July 2010
95
1
56-68